Cost-effectiveness of diagnostic strategies for the management of abnormal uterine bleeding (heavy menstrual bleeding and post-menopausal bleeding): A decision analysis

Health Technology Assessment

Volumn 18, Issue 24, 2014, Pages 1-201

  Cooper, Natalie A M ^a,b   Barton, Pelham M ^a   Breijer, Maria ^c   Caffrey, Orla ^a   Opmeer, Brent C ^c   Timmermans, Anne ^c   Mol, Ben W J ^c   Khan, Khalid S ^d   Clark, T Justin ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DECISION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ECONOMIC EVALUATION; ENDOMETRIAL DISEASE; ENDOMETRIUM ABLATION; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM POLYP; FEASIBILITY STUDY; FEMALE FERTILITY; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; INCREMENTAL COST EFFECTIVENESS RATIO; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MENORRHAGIA; MYOMECTOMY; PATIENT SATISFACTION; POST MENOPAUSAL BLEEDING; PREVALENCE; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SALINE INFUSION SONOGRAPHY; SALPINGOOOPHORECTOMY; SECONDARY HEALTH CARE; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SUBMUCOSAL FIBROID; SURVIVAL RATE; SURVIVAL TIME; SURVIVOR; TRANSVAGINAL ECHOGRAPHY; UTERINE ARTERY EMBOLIZATION; UTERUS BLEEDING; UTERUS MYOMA; WILLINGNESS TO PAY; ADULT; AGE DISTRIBUTION; AGED; BIOPSY; COMPLICATION; COST BENEFIT ANALYSIS; DECISION TREE; DIAGNOSTIC IMAGING; ECONOMICS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; FEMALE GENITAL SYSTEM; FERTILITY PRESERVATION; MIDDLE AGED; NATIONAL HEALTH SERVICE; PATHOLOGY; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREMENOPAUSE; PROCEDURES; UNITED KINGDOM; UTERINE HEMORRHAGE;

ADULT; AGE DISTRIBUTION; AGED; BIOPSY; COST-BENEFIT ANALYSIS; DECISION TREES; DIAGNOSTIC IMAGING; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ENGLAND; FEMALE; FERTILITY PRESERVATION; GENITALIA, FEMALE; HUMANS; HYSTERECTOMY; MENORRHAGIA; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; STATE MEDICINE; UTERINE HEMORRHAGE; WALES;

EID: 84900334394     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta18240     Document Type: Article

References (159)

1. Coulter A, Noone A, Goldacre M. General practitioners' referrals to specialist outpatient clinics. I. Why general practitioners refer patients to specialist outpatient clinics. BMJ 1989; 299: 304-6.
2. Bhattacharya S, Middleton LJ, Tsourapas A, Lee AJ, Champaneria R, Daniels JP, et al. Hysterectomy, endometrial ablation and mirena for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis. Health Technol Assess 2011; 15(19).
3. Coulter A, McPherson K, Vessey M. Do British women undergo too many or too few hysterectomies? Soc Sci Med 1988; 27: 987-94. http://dx. doi. org/10. 1016/0277-9536(88)90289-4.
4. Coulter A, Kelland J, Long A, Melvill A, O'Meara S. The management of menorrhagia. Eff Health Care 1995; 9: 1-14.
5. Coulter A, Peto V, Jenkinson C. Quality of life and patient satisfaction following treatment for menorrhagia. Fam Pract 1994; 11: 394-401. http://dx. doi. org/10. 1093/fampra/11. 4. 394.
6. Clark TJ, Khan KS, Foon R, Pattison H, Bryan S, Gupta JK. Quality of life instruments in studies of menorrhagia: a systematic review. Eur J Obstet Gynecol Reprod Biol 2002; 104: 96-104. http://dx. doi. org/10. 1016/S0301-2115(02)00076-3.
7. Jones GL, Kennedy SH, Jenkinson C. Health-related quality of life measurement in women with common benign gynecologic conditions: A systematic review. Am J Obstet Gynecol 2002; 187: 501-11. http://dx. doi. org/10. 1067/mob. 2002. 124940.
8. Gull B, Karlsson B, Milsom I, Granberg S. Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am J Obstet Gynecol 2003; 188: 401-8. http://dx. doi. org/10. 1067/mob. 2003. 154.
9. Gredmark T, Kvint S, Havel G, Mattsson LA. Histopathological findings in women with postmenopausal bleeding. Br J Obstet Gynaecol 1995; 102: 133-6. http://dx. doi. org/10. 1111/j. 1471-0528. 1995. tb09066. x.
10. Spencer CP, Whitehead MI. Endometrial assessment re-visited. Br J Obstet Gynaecol 1999; 106: 623-32. http://dx. doi. org/10. 1111/j. 1471-0528. 1999. tb08358. x.
11. National Institute for Health and Care Excellence. CG44 Heavy Menstrual Bleeding: NICE Guideline London: NICE; 2007. URL: www. nice. org. uk/nicemedia/pdf/CG44FullGuideline. pdf (accessed 10 February 2012).
12. Royal College of Obstetricians and Gynaecologists. The Initial Management of Menorrhagia. Evidence-Based Guidelines No. 1. London: Royal College of Obstetricians and Gynaecologists; 1998.
13. Reid PC, Coker A, Coltart R. Assessment of menstrual blood loss using a pictorial chart: a validation study. Br J Obstet Gynaecol 2000; 107: 320-2. http://dx. doi. org/10. 1111/j. 1471-0528. 2000. tb13225. x.
14. Wyatt KM, Dimmock PW, Walker TJ, O'Brien PM. Determination of total menstrual blood loss. Fertil Steril 2001; 76: 125-31. http://dx. doi. org/10. 1016/S0015-0282(01)01847-7.
15. Chimbira TH, Anderson AB, Naish C, Cope E, Turnbull AC. Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo. Br J Obstet Gynaecol 1980; 87: 1152-8. http://dx. doi. org/10. 1111/j. 1471-0528. 1980. tb04489. x.
16. Fraser IS, McCarron G, Markham R. A preliminary study of factors influencing perception of menstrual blood loss volume. Am J Obstet Gynecol 1984; 149: 788-93. http://dx. doi. org/10. 1016/0002-9378(84)90123-6.
17. Hallberg L, Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest 1964; 16: 244-8. http://dx. doi. org/10. 3109/00365516409060511.
18. Clark TJ, Gupta JK. Handbook of Outpatient Hysteroscopy. A Complete Guide to Diagnosis and Therapy. 1st edn. London: Hodder Education; 2005.
19. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of 'untreated' hyperplasia in 170 patients. Cancer 1985; 56: 403-12. http://dx. doi. org/10. 1002/1097-0142(19850715)56: 2%3C403:: AID-CNCR2820560233%3E3. 0. CO; 2-X.
20. Clark TJ, Mann CH, Shah N, Khan KS, Song F, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial hyperplasia. Acta Obstet Gynecol Scand 2001; 80: 784-93. http://dx. doi. org/10. 1034/j. 1600-0412. 2001. 080009784. x.
21. Clark TJ, Mann CH, Shah N, Khan KS, Song F, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. BJOG 2002; 109: 313-21. http://dx. doi. org/10. 1016/S1470-0328(02)01088-1.
22. Goldstein SR. Saline infusion sonohysterography. Clin Obstet Gynecol 1996; 39: 248-58. http://dx. doi. org/10. 1097/00003081-199603000-00023.
23. Wolman I, Jaffa AJ, Kupferminz M, Geva E, Gordon D, Lessing JB, et al. Transvaginal sonohysterography: a method for the evaluation of the endometrial cavity-4 years' experience. Ultrasound International 1999; 5: 79-86.
24. Ossola MW, Bertulessi C, Iasi L, Bianchini B, Hanozet F, Grassini E, et al. Comparison of saline infusion sonography to transvaginal echography and hysteroscopy in the diagnostic evaluation of abnormal uterine bleeding. Italian J Gynaecol Obstet 1999; 11: 145-50.
25. Bakour SH, Jones SE, O'Donovan P. Ambulatory hysteroscopy: evidence-based guide to diagnosis and therapy. Best Pract Res Clin Obstet Gynaecol 2006; 20: 953-75. http://dx. doi. org/10. 1016/j. bpobgyn. 2006. 06. 004.
26. Gulumser C, Narvekar N, Pathak M, Palmer E, Parker S, Saridogan E. See-and-treat outpatient hysteroscopy: an analysis of 1109 examinations. Reprod Biomed Online 2010; 20: 423-9. http://dx. doi. org/10. 1016/j. rbmo. 2009. 11. 024.
27. Clark TJ, Godwin J, Khan KS, Gupta JK. Ambulatory endoscopic treatment of symptomatic benign endometrial polyps. A feasibility study. Gynaecol Endosc 2002; 11: 91-7. http://dx. doi. org/10. 1046/j. 1365-2508. 2002. 00485. x.
28. Bettocchi S, Nappi L, Ceci O, Selvaggi L. What does 'diagnostic hysteroscopy' mean today? The role of the new techniques. Curr Opin Obstet Gynecol 2003; 15: 303-8. http://dx. doi. org/10. 1097/01. gco. 0000084241. 09900. c8.
29. Critchley HOD, Warner P, Lee AJ, Brechin S, Guise J, Graham B. Evaluation of abnormal uterine bleeding: comparison of three outpatient procedures within cohorts defined by age and menopausal status. Health Technol Assess 2004; 8(34).
30. De Vries LD, Dijkhuizen FPHL, Mol BWJ, Brolmann HAM, Moret E, Heintz APM. Comparison of transvaginal sonography, saline infusion sonography, and hysteroscopy in premenopausal women with abnormal uterine bleeding. J Clin Ultrasound 2000; 28: 217-23. http://dx. doi. org/10. 1002/(SICI)1097-0096(200006)28: 5%3C217:: AID-JCU2%3E3. 3. CO; 2-2.
31. Clark TJ. Outpatient hysteroscopy and ultrasonography in the management of endometrial disease. Curr Opin Obstet Gynecol 2004; 16: 305-11. http://dx. doi. org/10. 1097/01. gco. 0000136491. 26463. c2.
32. Milsom I, Andersson K, Andersch B, Rybo G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991; 164: 879-83. http://dx. doi. org/10. 1016/S0002-9378(11) 90533-X.
33. Lahteenmaki P, Haukkamaa M, Puolakka J, Riikonen U, Sainio S, Suvisaari J, et al. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ 1998; 316: 1122-6. http://dx. doi. org/10. 1136/bmj. 316. 7138. 1122.
34. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivela A, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004; 291: 1456-63. http://dx. doi. org/10. 1001/jama. 291. 12. 1456.
35. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivela A, et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 2001; 357: 273-7. http://dx. doi. org/10. 1016/S0140-6736(00)03615-1.
36. Hurskainen R, Teperi J, Aalto AM, Grenman S, Kivela A, Kujansuu E, et al. Levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of essential menorrhagia: predictors of outcome. Acta Obstet Gynecol Scand 2004; 83: 401-3. http://dx. doi. org/10. 1111/j. 0001-6349. 2004. 00440. x.
37. Varma R, Soneja H, Bhatia K, Ganesan R, Rollason T, Clark TJ, et al. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia-a long-term follow-up study. Eur J Obstet Gynecol Reprod Biol 2008; 139: 169-75. http://dx. doi. org/10. 1016/j. ejogrb. 2008. 02. 022.
38. Gallos ID, Krishan P, Shehmar M, Ganesan R, Gupta JK. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study. Hum Reprod 2013; 28: 2966-71.
39. Cooper KG, Jack SA, Parkin DE, Grant AM. Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. BJOG 2001; 108: 1222-8. http://dx. doi. org/10. 1016/S0306-5456(01) 00275-3.
40. Nathani F, Clark TJ. Uterine polypectomy in the management of abnormal uterine bleeding: a systematic review. J Minim Invasive Gynecol 2006; 13: 260-8. http://dx. doi. org/10. 1016/j. jmig. 2006. 03. 015.
41. Lieng M, Istre O, Qvigstad E. Treatment of endometrial polyps: a systematic review. Acta Obstet Gynecol Scand 2010; 89: 992-1002. http://dx. doi. org/10. 3109/00016349. 2010. 493196.
42. Hart R, Molnar V, Magos A. Long-term follow-up of hysteroscopic myomectomy assessed by survival analysis. BJOG 1999; 106: 700-5. http://dx. doi. org/10. 1111/j. 1471-0528. 1999. tb08370. x.
43. Emanuel MH, Wamsteker K, Hart AA, Metz G, Lammes FB. Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding. Obstet Gynecol 1999; 93: 743-8. http://dx. doi. org/10. 1016/S0029-7844(98)00558-4.
44. Vercellini P, Zaina B, Yaylayan L, Pisacreta A, De O, Crosignani PG. Hysteroscopic myomectomy: long-term effects on menstrual pattern and fertility. Obstet Gynecol 1999; 94: 341-7. http://dx. doi. org/10. 1016/S0029-7844(99)00346-4.
45. Clark TJ, Mahajan D, Sunder P, Gupta JK. Hysteroscopic treatment of symptomatic submucous fibroids using a bipolar intrauterine system: a feasibility study. Eur J Obstet Gynecol Reprod Biol 2002; 100: 237-42. http://dx. doi. org/10. 1016/S0301-2115(01)00485-7.
46. Varma R, Soneja H, Clark TJ, Gupta JK. Hysteroscopic myomectomy for menorrhagia using Versascope bipolar system: efficacy and prognostic factors at a minimum of one year follow up. Eur J Obstet Gynecol Reprod Biol 2009; 142: 154-9. http://dx. doi. org/10. 1016/j. ejogrb. 2008. 10. 006.
47. Clark TJ, Khan KS, Gupta JK. Current practice for the treatment of benign intrauterine polyps: a national questionnaire survey of consultant gynaecologists in UK. Eur J Obstet Gynecol Reprod Biol 2002; 103: 65-7. http://dx. doi. org/10. 1016/S0301-2115(02)00011-8.
48. Litta P, Cosmi E, Saccardi C, Esposito C, Rui R, Ambrosini G. Outpatient operative polypectomy using a 5 mm-hysteroscope without anaesthesia and/or analgesia: advantages and limits. Eur J Obstet Gynecol Reprod Biol 2008; 139: 210-14.
49. Capobianco G, Vargiu N, Dessole F, Milia L, Dessole S. Office hysteroscopy for uterine intracavitary pathologies: see and treat approach. Gynecol Surg 2009; 6(Suppl. 1): 72.
50. Marsh FA, Rogerson LJ, Duffy SRG. A randomised controlled trial comparing outpatient versus daycase endometrial polypectomy. BJOG 2006; 113: 896-901. http://dx. doi. org/10. 1111/j. 1471-0528. 2006. 00967. x.
51. Clark TJ, Middleton LJ, Cooper NAM, Diwakar L, Denny E, Smith P, et al. A randomised controlled trial of outpatient versus inpatient polyp treatment for abnormal uterine bleeding. Health Technol Assess 2014; in press.
52. Pelage JP, Le O, Soyer P, Kardache M, Dahan H, Abitbol M, et al. Fibroid-related menorrhagia: treatment with superselective embolization of the uterine arteries and midterm follow-up. Radiology 2000; 215: 428-31.
53. The REST Investigators. Uterine artery embolization versus surgery for symptomatic uterine fibroids. N Eng J Med 2007; 356: 360-70.
54. Pinto I, Chimeno P, Romo L, Haya J, De la Cal M, Bajo J. Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology 2003; 226: 425-31.
55. Lefebvre G, Vilos G, Allaire C, Jeffrey J, Arneja J, Birch C, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can: JOGC 2003; 25: 396-418.
56. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83. http://dx. doi. org/10. 1097/00005650-199206000-00002.
57. Jenkinson C, Peto V, Coulter A. Making sense of ambiguity: evaluation in internal reliability and face validity of the SF-36 questionnaire in women presenting with menorrhagia. Quality Health Care 1996; 5: 9-12. http://dx. doi. org/10. 1136/qshc. 5. 1. 9.
58. Lamping DL, Rowe P, Clarke A, Black N, Lessof L. Development and validation of the Menorrhagia Outcomes Questionnaire. Br J Obstet Gynaecol 1998; 105: 766-79. http://dx. doi. org/10. 1111/j. 1471-0528. 1998. tb10209. x.
59. Shaw RW, Brickley MR, Evans L, Edwards MJ. Perceptions of women on the impact of menorrhagia on their health using multi-attribute utility assessment. Br J Obstet Gynaecol 1998; 105: 1155-9. http://dx. doi. org/10. 1111/j. 1471-0528. 1998. tb09968. x.
60. Crow R, Gage H, Hampson S, Hart J, Kimber A, Storey L, et al. The measurement of satisfaction with healthcare: implications for practice from a systematic review of the literature. Health Technol Assess 2002; 6(32).
61. Middleton LJ, Champaneria R, Daniels JP, Bhattacharya S, Cooper KG, Hilken NH, et al. Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients. BMJ 2010; 341: c3929. http://dx. doi. org/10. 1136/bmj. c3929.
62. Lethaby A, Hickey M, Garry R, Penninx J. Endometrial resection/ablation techniques for heavy menstrual bleeding. Cochrane Database Syst Rev 2009; 4: CD001501. http://dx. doi. org/10. 1002/14651858. CD001501. pub3.
63. Kato I, Toniolo P, Akhmedkhanov A, Koenig KL, Shore R, Zeleniuch-Jacquotte A. Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol 1998; 51: 1271-6. http://dx. doi. org/10. 1016/S0895-4356(98)00119-X.
64. Bachmann LM, ter Riet G, Clark TJ, Gupta JK, Khan KS. Probability analysis for diagnosis of endometrial hyperplasia and cancer in postmenopausal bleeding: an approach for a rational diagnostic workup. Acta Obstet Gynecol Scand 2003; 82: 564-9. http://dx. doi. org/10. 1034/j. 1600-0412. 2003. 00176. x.
65. FIGO Committee on Gynecologic Oncology. Staging Classifications and Clinical Practice Guidelines for Gynaecological Cancers. 2000. URL: www. igcs. org/professionalEducation/treatmentResources/figoStaging. html. (accessed 21 January 2012).
66. Scottish Intercollegiate Guidelines Network. Investigation of Post-Menopasual Bleeding. Edinburgh: Royal College of Physicians; 2002.
67. Ong S, Duffy T, Lenehan P, Murphy J. Endometrial pipelle biopsy compared to conventional dilatation and curettage. Irish J Med Sci 1997; 166: 47-9. http://dx. doi. org/10. 1007/BF02939779.
68. Epstein E, Skoog L, Valentin L. Comparison of Endorette and dilatation and curettage for sampling of the endometrium in women with postmenopausal bleeding. Acta Obstet Gynecol Scand 2001; 80: 959-64. http://dx. doi. org/10. 1034/j. 1600-0412. 2001. 801015. x.
69. Clark TJ, Barton PM, Coomarasamy A, Gupta JK, Khan KS. Investigating postmenopausal bleeding for endometrial cancer: cost-effectiveness of initial diagnostic strategies. BJOG 2006; 113: 502-10. http://dx. doi. org/10. 1111/j. 1471-0528. 2006. 00914. x.
70. Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP. Cost-effectiveness of the use of transvaginal sonography in the evaluation of postmenopausal bleeding. Maturitas 2003; 45: 275-82. http://dx. doi. org/10. 1016/S0378-5122(03)00152-X.
71. Burbos N, Musonda P, Giarenis I, Shiner AM, Giamougiannis P, Morris E, et al. Age-related differential diagnosis of vaginal bleeding in postmenopausal women: a series of 3047 symptomatic postmenopausal women. Menopause Int 2010; 16: 5-8. http://dx. doi. org/10. 1258/mi. 2010. 010005.
72. Ferrazzi E, Torri V, Trio D, Zannoni E, Filiberto S, Dordoni D. Sonographic endometrial thickness: a useful test to predict atrophy in patients with postmenopausal bleeding. An Italian multicenter study. Ultrasound Obstet Gynecol 1996; 7: 315-21. http://dx. doi. org/10. 1046/j. 1469-0705. 1996. 07050315. x.
73. Opmeer BC, Van HC, Heintz APM, Burger CW, Bossuyt PMM, Mol BWJ. Improving the existing diagnostic strategy by accounting for characteristics of the women in the diagnostic work up for postmenopausal bleeding. BJOG 2007; 114: 51-8. http://dx. doi. org/10. 1111/j. 1471-0528. 2006. 01168. x.
74. Musonda P, Burbos N, Duncan TJ, Crocker SG, Morris EP, Nieto JJ. Comparing the performance of two clinical models in estimating the risk of endometrial cancer in symptomatic postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2011; 159: 433-8. http://dx. doi. org/10. 1016/j. ejogrb. 2011. 09. 005.
75. Anderson KE, Anderson E, Mink PJ, Hong CP, Kushi LH, Sellers TA, et al. Diabetes and endometrial cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 2001; 10: 611-16.
76. Gull B, Karlsson B, Milsom I, Granberg S. Factors associated with endometrial thickness and uterine size in a random sample of postmenopausal women. Am J Obstet Gynecol 2001; 185: 386-91. http://dx. doi. org/10. 1067/mob. 2001. 115869.
77. McPherson CP, Sellers TA, Potter JD, Bostick RM, Folsom AR. Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study. Am J Epidemiol 1996; 143: 1195-202. http://dx. doi. org/10. 1093/oxfordjournals. aje. a008707.
78. Tabor A, Watt HC, Wald NJ. Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstet Gynecol 2002; 99: 663-70. http://dx. doi. org/10. 1016/S0029-7844(01)01771-9.
79. van Doorn HC, Opmeer BC, Jitze DM, Kruitwagen RF, Dijkhuizen FP, Mol BW. The relation between age, time since menopause, and endometrial cancer in women with postmenopausal bleeding. Int J Gynecol Cancer 2007; 17: 1118-23. http://dx. doi. org/10. 1111/j. 1525-1438. 2007. 00925. x.
80. Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000; 11: 185-92.
81. Xu WH, Xiang YB, Ruan ZX, Zheng W, Cheng JR, Dai Q, et al. Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case-control study in urban Shanghai. Int J Cancer 2004; 108: 613-19.
82. Medverd JR, Dubinsky TJ. Cost analysis model: US versus endometrial biopsy in evaluation of peri-and postmenopausal abnormal vaginal bleeding. Radiology 2002; 222: 619-27.
83. Bakour SH, Dwarakanath LS, Khan KS, Newton JR, Gupta JK. The diagnostic accuracy of ultrasound scan in predicting endometrial hyperplasia and cancer in postmenopausal bleeding. Acta Obstet Gynecol Scand 1999; 78: 447-51. http://dx. doi. org/10. 1034/j. 1600-0412. 1999. 780519. x.
84. Smith-Bindman R, Kerlikowske K, Feldstein VA, Subak L, Scheidler J, Segal M, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998; 280: 1510-17. http://dx. doi. org/10. 1001/jama. 280. 17. 1510.
85. Creasman W, Odicino F, Maisonneuve P, Quinn M, Beller U, Benedet J, et al. Carcinoma of the corpus uteri. Int J Gynecol Obstet 2006; 95(Suppl. 1): S105-43. http://dx. doi. org/10. 1016/S0020-7292(06)60031-3.
86. Higham JM, Shaw RW. Clinical associations with objective menstrual blood volume. Eur J Obstet Gynecol Reprod Biol 1999; 82: 73-6. http://dx. doi. org/10. 1016/S0301-2115(98)00224-3.
87. Fuentes JA. [In-office hysteroscopic polypectomy: eight years analysis.] Ginecol Obstet Mex 2007; 75: 341-6.
88. Gonzalez A, Fernandez J, Rodrguez A. Operative office hysteroscopy. Gynecol Surg 2010; 7: S199.
89. Bayer Healthcare. Mirena® Prescribing Information. 2013 URL: http://labeling. bayerhealthcare. com/html/products/pi/Mirena_Pl/pdf (accessed 10 March 2014).
90. Hologic Inc. NovaSure® Instructions for Use. 2011 URL: www. novasure. com/pdf/info/Instructions. pdf (accessed 10 March 2014).
91. Ethicon Women's Health and Urology. Instructions for Use Gynecare® Thermachoice® III Uterine Balloon Therapy System. 2010. Ref Type: www. ethicon360emea. com/sites/default/files/products/C03. 23_Thermachoice. pdf (accessed 4 December 2011).
92. Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, Muysers C, Jensen JT. Levonorgestrelreleasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 2010; 116: 625-32. http://dx. doi. org/10. 1097/AOG. 0b013e3181ec622b.
93. Lethaby A, Shepperd S, Cooke I, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev 2000; 2: CD000329.
94. de Kroon CD, de Bock GH, Dieben SW, Jansen FW. Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG 2003; 110: 938-47. http://dx. doi. org/10. 1111/j. 1471-0528. 2003. 02472. x.
95. Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 2002; 288: 1610-21. http://dx. doi. org/10. 1001/jama. 288. 13. 1610.
96. Farquhar C, Ekeroma A, Furness S, Arroll B. A systematic review of transvaginal ultrasonography, sonohysterography and hysteroscopy for the investigation of abnormal uterine bleeding in premenopausal women. Acta Obstet Gynecol Scand 2003; 82: 493-504. http://dx. doi. org/10. 1034/j. 1600-0412. 2003. 00191. x.
97. Giorda G, Crivellari D, Veronesi A, Perin T, Campagnutta E, Carbone A, et al. Comparison of ultrasonography, hysteroscopy, and biopsy in the diagnosis of endometrial lesions in postmenopausal tamoxifen-treated patients. Acta Obstet Gynecol Scand 2002; 81: 975-80. http://dx. doi. org/10. 1034/j. 1600-0412. 2002. 811013. x.
98. Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 2008; 31: 73-85. http://dx. doi. org/10. 1007/s00270-007-9195-2.
99. van Dongen H, de Kroon CD, Jacobi CE, Trimbos JB, Jansen FW. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG 2007; 114: 664-75. http://dx. doi. org/10. 1111/j. 1471-0528. 2007. 01326. x.
100. Emanuel MH, Verdel MJC, Stas H, Wamsteker K, Lammes FB. An audit of true prevalence of intra-uterine pathology: the hysteroscopical findings controlled for patient selection in 1202 patients with abnormal uterine bleeding. Gynaecol Endosc 1995; 4: 237-41.
101. Dreisler E, Stampe SS, Ibsen PH, Lose G. Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years. Ultrasound Obstet Gynecol 2009; 33: 102-8. http://dx. doi. org/10. 1002/uog. 6259.
102. Lasmar RB, Dias R, Barrozo PR, Oliveira MA, Coutinho ES, da Rosa DB. Prevalence of hysteroscopic findings and histologic diagnoses in patients with abnormal uterine bleeding. Fertil Steril 2008; 89: 1803-7. http://dx. doi. org/10. 1016/j. fertnstert. 2007. 05. 045.
103. Clevenger-Hoeft M, Syrop CH, Stovall DW, Van Voorhis BJ. Sonohysterography in premenopausal women with and without abnormal bleeding. Obstet Gynecol 1999; 94: 516-20. http://dx. doi. org/10. 1016/S0029-7844(99)00345-2.
104. Lurie S, Piper I, Woliovitch I, Glezerman M. Age-related prevalence of sonographicaly confirmed uterine myomas. J Obstet Gynaecol 2005; 25: 42-3. http://dx. doi. org/10. 1080/01443610400024583.
105. Iram S, Musonda P, Ewies AAA. Premenopausal bleeding: when should the endometrium be investigated? A retrospective non-comparative study of 3006 women. Eur J Obstet Gynecol Reprod Biol 2010; 148: 86-9. http://dx. doi. org/10. 1016/j. ejogrb. 2009. 09. 023.
106. Basu A, Lewis P. Transvaginal scan, saline infusion sonography and hysteroscopy in abnormal uterine bleeding. Int J Gynecol Obstet 2009; 107: S120-1. http://dx. doi. org/10. 1016/S0020-7292 (09)60470-7.
107. Smith-Bindman R. Diagnostic imaging in the differential diagnosis of vaginal bleeding and breast mass. Adv Stud Med 2004; 4: 476-82.
108. de Kroon CD, de Bock GH, Dieben SWM, Jansen FW. Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG 2003; 110: 938-47.
109. Grimbizis GF, Tsolakidis D, Mikos T, Anagnostou E, Asimakopoulos E, Stamatopoulos P, et al. A prospective comparison of transvaginal ultrasound, saline infusion sonohysterography, and diagnostic hysteroscopy in the evaluation of endometrial pathology. Fertil Steril 2010; 94: 2720-5. http://dx. doi. org/10. 1016/j. fertnstert. 2010. 03. 047.
110. Botsis D, Kassanos D, Antoniou G, Pyrgiotis E, Karakitsos P, Kalogirou D. Adenomyoma and leiomyoma: differential diagnosis with transvaginal sonography. J Clin Ultrasound 1997; 26: 21-5. http://dx. doi. org/10. 1002/(SICI)1097-0096(199801)26: 1%3C21:: AID-JCU5%3E3. 3. CO; 2-V.
111. Vercellini P, Cortesi I, Oldani S, Moschetta M, De O, Crosignani PG. The role of transvaginal ultrasonography and outpatient diagnostic hysteroscopy in the evaluation of patients with menorrhagia. Human Reprod 1997; 12: 1768-71. http://dx. doi. org/10. 1093/humrep/12. 8. 1768.
112. Aslam M, Ijaz L, Tariq S, Shafqat K, Meher UN, Ashraf R, et al. Comparison of transvaginal sonography and saline contrast sonohysterography in women with abnormal uterine bleeding: correlation with hysteroscopy and histopathology. Int J Health Sci 2007; 1: 17-24.
113. Goldschmit R, Katz Z, Blickstein I, Caspi B, Dgani R. The accuracy of endometrial pipelle sampling with and without sonographic measurement of endometrial thickness. Obstet Gynecol 1993; 82: 727-30.
114. Evidence Based Medicine T. Stats Calculator. 2011. URL: http://ktclearinghouse. ca/cebm/practise/ca/calculators/statscalc (accessed 8 November 2011).
115. Angioni S, Loddo A, Milano F, Piras B, Minerba L, Melis GB. Detection of benign intracavitary lesions in postmenopausal women with abnormal uterine bleeding: a prospective comparative study on outpatient hysteroscopy and blind biopsy. J Minim Invasive Gynecol 2008; 15: 87-91. http://dx. doi. org/10. 1016/j. jmig. 2007. 10. 014.
116. Lethaby AE, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 2005; 4: CD000329.
117. Longinotti MK, Jacobson GF, Hung YY, Learman LA. Probability of hysterectomy after endometrial ablation. Obstet Gynecol 2008; 112: 1214-20. http://dx. doi. org/10. 1097/AOG. 0b013e31818c1766.
118. Hirst A, Dutton S, Wu O, Briggs A, Edwards C, Waldenmaier L, et al. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study. Health Technol Assess 2008; 12(5).
119. van Dongen H, Janssen CA, Smeets MJ, Emanuel MH, Jansen FW. The clinical relevance of hysteroscopic polypectomy in premenopausal women with abnormal uterine bleeding. BJOG 2009; 116: 1387-90. http://dx. doi. org/10. 1111/j. 1471-0528. 2009. 02145. x.
120. Lieng M, Istre O, Sandvik L, Engh V, Qvigstad E. Clinical effectiveness of transcervical polyp resection in women with endometrial polyps: randomized controlled trial. J Minim Invasive Gynecol 2010; 17: 351-7. http://dx. doi. org/10. 1016/j. jmig. 2010. 01. 019.
121. Camanni M, Bonino L, Delpiano EM, Ferrero B, Migliaretti G, Deltetto F. Hysteroscopic management of large symptomatic submucous uterine myomas. J Minim Invasive Gynecol 2010; 17: 59-65. http://dx. doi. org/10. 1016/j. jmig. 2009. 10. 013.
122. Clark TJ, Mahajan D, Sunder P, Gupta JK. Hysteroscopic treatment of symptomatic submucous fibroids using a bipolar intrauterine system: a feasibility study. Eur J Obstet Gynecol Reprod Biol 2002; 100: 237-42. http://dx. doi. org/10. 1016/S0301-2115(01)00485-7.
123. Bourdel N, Bonnefoy C, Jardon K, Da D, Tognazza E, Rabischong B, et al. [Hysteroscopic myomectomy: recurrence and satisfaction survey at short-and long-term.] J Gynecol Obstet Biol Reprod 2011; 40: 116-22.
124. Cravello L, Farnarier J, Roger V, D'Ercole C, Blanc B. [Hysteroscopic myomectomy. Functional results with an average follow-up of 6 years.] J Gynecol Obstet Biol Reprod 1998; 27: 593-7.
125. Munoz JL, Jimenez JS, Hernandez C, Vaquero G, Perez C, Noguero R, et al. Hysteroscopic myomectomy: our experience and review. JSLS 2003; 7: 39-48.
126. Polena V, Mergui JL, Perrot N, Poncelet C, Barranger E, Uzan S. Long-term results of hysteroscopic myomectomy in 235 patients. Eur J Obstet Gynecol Reprod Biol 2007; 130: 232-7. http://dx. doi. org/10. 1016/j. ejogrb. 2006. 01. 014.
127. Haynes PJ, Hodgson H, Anderson AB, Turnbull AC. Measurement of menstrual blood loss in patients complaining of menorrhagia. Br J Obstet Gynaecol 1977; 84: 763-8. http://dx. doi. org/10. 1111/j. 1471-0528. 1977. tb12490. x.
128. van der Kooij SM, Bipat S, Hehenkamp WJ, Ankum WM, Reekers JA. Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and metaanalysis. Am J Obstet Gynecol 2011; 205: 317. http://dx. doi. org/10. 1016/j. ajog. 2011. 03. 016.
129. Gupta JK, Sinha AS, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev 2006; 1: CD005073.
130. Department of Health. NHS Reference Costs 2009-2010. London: Department of Health; 2011. URL: www. dh. gov. uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_123459.
131. British Medical Association and Royal Pharmaceutical Society of Great Britain. British national formulary. No. 57, 2009. London: BMA and RPS; 2009.
132. Unit Costs of Health and Social Care 2010. Canterbury: PSSRU, University of Kent; 2010. URL: www. pssru. ac. uk/pdf/uc/uc2010/uc2010_s10. pdf (accessed 21 March 2012).
133. Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application. Pharmacoeconomics 2000; 17: 461-77. http://dx. doi. org/10. 2165/00019053-200017050-00005.
134. Elwyn G, Edwards A, Eccles M, Rovner D. Decision analysis in patient care. Lancet 2001; 358: 571-4. http://dx. doi. org/10. 1016/S0140-6736(01)05709-9.
135. Epstein E. Management of postmenopausal bleeding in Sweden: a need for increased use of hydrosonography and hysteroscopy. Acta Obstet Gynecol Scand 2004; 83: 89-95. http://dx. doi. org/10. 1111/j. 1600-0412. 2004. 00357. x.
136. Goldstein RB, Bree RL, Benson CB, Benacerraf BR, Bloss JD, Carlos R, et al. Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Consensus Conference statement. J Ultrasound Med 2001; 20: 1025-36.
137. NVOG (Dutch Society of Obstetrics and Gynaecology). NVOG-richtlijnAbnormaal vaginaal bloedverlies in de menopauze. 2003. URL: www. artsennet. nl/Richtlijnen/Richtlijn/43092/Abnormaal-vaginaal-bloedverlies-in-de-postmenopauze. htm (accessed 2 February 2012).
138. Lotfallah H, Farag K, Hassan I, Watson R. One-stop hysteroscopy clinic for postmenopausal bleeding. J Reprod Med 2005; 50: 101-7.
139. Luk KL, Tang LCH. Modern strategy in the diagnosis of postmenopausal bleeding. Hong Kong Pract 1998; 20: 421-9.
140. MacNab W, Majumudar T, Abdel-Rahman H. Incidence and management of endometrial polyps in women with post-menopausal PV bleeding (PMB) in the office setting. Gynecol Surg 2010; 7: S92.
141. Panda JK. One-stop clinic for postmenopausal bleeding. J Reprod Med 2002; 47: 761-6.
142. Gupta JK, Wilson S, Desai P, Hau C. How should we investigate women with postmenopausal bleeding? Acta Obstet Gynecol Scand 1996; 75: 475-9. http://dx. doi. org/10. 3109/00016349609033357.
143. Gupta JK, Chien PFW, Voit D, Clark TJ, Khan KS. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand 2002; 81: 799-816. http://dx. doi. org/10. 1034/j. 1600-0412. 2001. 810902. x.
144. Clark TJ, Bakour SH, Gupta JK, Khan KS. Evaluation of outpatient hysteroscopy and ultrasonography in the diagnosis of endometrial disease. Obstet Gynecol 2002; 99: 1001-7. http://dx. doi. org/10. 1016/S0029-7844(02)01976-2.
145. Rogerson L, Downes E. How do UK gynaecologists manage endometrial carcinoma? A national survey. Eur J Gynaecol Oncol 1998; 19: 331-2.
146. National Cancer Institute. Endometrial Cancer Treatment PDQ. 2012. URL: www. cancer. gov/cancertopics/pdq/treatment/endometrial/Patient/page1 (accessed 2 February 2012).
147. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009; 105: 103-4. http://dx. doi. org/10. 1016/j. ijgo. 2009. 02. 012.
148. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press; 2006.
149. Clark TJ, Samuel N, Malick S, Middleton LJ, Daniels J, Gupta JK. Bipolar radiofrequency compared with thermal balloon endometrial ablation in the office: a randomized controlled trial. Obstet Gynecol 2011; 117: 109-18.
150. Sculpher M. A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. Int J Technol Assess Health Care 1998; 14: 302-19. http://dx. doi. org/10. 1017/S0266462300012277.
151. Dijkhuizen FP, Mol BW, Bongers MY, lmann HA, Heintz AP. Cost-effectiveness of transvaginal sonography and saline infused sonography in the evaluation of menorrhagia. Int J Gynaecol Obstet 2003; 83: 45-52. http://dx. doi. org/10. 1016/S0020-7292(03)00080-8.
152. Timmermans A, Opmeer BC, Veersema S, Mol BW. Patients' preferences in the evaluation of postmenopausal bleeding. BJOG 2007; 114: 1146-9. http://dx. doi. org/10. 1111/j. 1471-0528. 2007. 01424. x.
153. Office for National Statistics. Statistical Bulletin: Interim Life Tables, England and Wales, 2010-2012. URL: www. ons. gov. uk/ons/rel/lifetables/interim-life-tables/2010-2012/stbilt2012. html (accessed 10 March 2014).
154. Department of Health. NHS reference costs 2009-2010. London: Department of Health; 2011. URL: www. dh. gov. uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_123459 (accessed 21 January 2014).
155. Reinhold C, McCarthy S, Bret PM, Mehio A, Atri M, Zakarian R, et al. Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation. Radiology 1996; 199: 151-8.
156. Timmermans A, van H, Mol BW, Veersema S, Jansen FW. Hysteroscopy and removal of endometrial polyps: a Dutch survey. Eur J Obstet Gynecol Reprod Biol 2008; 138: 76-9. http://dx. doi. org/10. 1016/j. ejogrb. 2007. 05. 016.
157. Brechin ST, Cameron AM, Paterson AR, Williams HOD, Critchley. Intrauterine polyps-a cause of unscheduled bleeding in women using the levonorgestrel intrauterine system. Hum Reprod 2000; 15: 650-2. http://dx. doi. org/10. 1093/humrep/15. 3. 650.
158. Mercorio F, De R, Di A, Cerrota G, Bifulco G, Vanacore F, et al. The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia. Contraception 2003; 67: 277-80. http://dx. doi. org/10. 1016/S0010-7824(02)00522-X.
159. Timmermans A, Veersema S, Van TC, Van LF, V, Opmeer BC, Bongers MY, et al. Should endometrial polyps be removed in patients with postmenopausal bleeding?-an assessment of study designs and report of a failed randomised controlled trial (ISRCTN73825127). BJOG 2009; 116: 1391-5. http://dx. doi. org/10. 1111/j. 1471-0528. 2009. 02234. x.